New York City based Phosplatin Therapeutics is raising $18,400,000.00 in New Debt Financing.
New York City, NY – According to filings with the U.S. Securities and Exchange Commission, Phosplatin Therapeutics is raising $18,400,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer,…